Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06049836
Other study ID # FIICNRHoloLiver
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 15, 2023
Est. completion date February 1, 2024

Study information

Verified date February 2024
Source Federico II University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this trial is to compare the evaluation of 3D liver models visualised as holograms with HoloLens 2 and on digital PDF files in HPB surgical trainees. The main questions it aims to answer are: - Do the holographic models allow a superior accuracy in terms of anatomical evaluation and surgical planning? - Is there any difference in terms of time consumed and Task Load Index? Participants will analyse cases through both modalities and answer a questionnaire.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date February 1, 2024
Est. primary completion date November 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - General Surgery Trainees with at least 6 months experience in HPB surgery Exclusion Criteria: - No informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Holograms
Clinical decision making based on visualising liver 3D holographic augmented reality liver models
PDF
Clinical decision making based on visualisation of 3D liver rendering on computer monitors on a PDF file

Locations

Country Name City State
Italy Federico II University Naples

Sponsors (2)

Lead Sponsor Collaborator
Federico II University ICAR (Istituto di Calcolo e Reti ad Alte Prestazioni) - CNR (Consiglio Nazionale delle Ricerche)

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Diagnostic and planning accuracy Correctly identify anatomy and appropriate surgical planning Residents' decision-making accuracy when reviewing patient data and 3D liver models using Holograms or on PDF, measured by comparing their performance.
The measurement tool will be a questionnaire consisting of 11 questions, rate of correct answers will be recorded (e.g. 8/10 correct answers) and higher scores mean a better outcome.
Immediately after completing the evaluation
Secondary Time consumed Analyse the time spent for the evaluation of the cases and complete the questionnaire Assessed by total time needed to make decision for 15 patient cases in minutes Immediately after completing the evaluation
Secondary NASA Task Load Index Analyse the NASA TLI score for each participant to evaluate the cases by conducting a subjective mental workload assessment rating performance across six dimensions to determine an overall workload rating:
Mental demand - how much thinking, deciding, or calculating was required to perform the task.
Physical demand - the amount and intensity of physical activity required to complete the task.
Temporal demand - the amount of time pressure involved in completing the task.
Effort - how hard does the participant have to work to maintain their level of performance?
Performance - the level of success in completing the task.
Frustration level - how insecure, discouraged, or secure or content the participant felt during the task.
Each participant gives a rating for each subscale from 1 (low) to 20 (high) and the TLX will calculate the overall worklaod score between 0 and 100
Immediately after completing the evaluation
See also
  Status Clinical Trial Phase
Terminated NCT01020812 - Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma Phase 1/Phase 2
Completed NCT04959630 - Immersive Virtual Reality Environment for Complex Cognitive Skills Curricular Training in Liver Surgery N/A
Completed NCT01135849 - B-Receptor Signaling in Cardiomyopathy N/A
Recruiting NCT04010071 - Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors Phase 2
Recruiting NCT04709445 - Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses N/A
Terminated NCT01151761 - PII of SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation Phase 2
Active, not recruiting NCT04501913 - Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
Withdrawn NCT03818997 - Combination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric Cancer Phase 2
Completed NCT04642664 - Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer Phase 2
Not yet recruiting NCT03760289 - DKN-01/Atezolizumab as Second Line Treatment of biliarY Tract Cancer and in combiNAtion or Not With Paclitaxel as Second Line treatMent of esophagogastrIC Cancer Phase 2
Terminated NCT00767234 - Permission to Collect Blood Over Time for Research N/A